[go: up one dir, main page]

FR1368727A - Estradiol derivatives and method of preparation - Google Patents

Estradiol derivatives and method of preparation

Info

Publication number
FR1368727A
FR1368727A FR860746A FR860746A FR1368727A FR 1368727 A FR1368727 A FR 1368727A FR 860746 A FR860746 A FR 860746A FR 860746 A FR860746 A FR 860746A FR 1368727 A FR1368727 A FR 1368727A
Authority
FR
France
Prior art keywords
preparation
estradiol derivatives
estradiol
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR860746A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR860746A priority Critical patent/FR1368727A/en
Priority to FR869787A priority patent/FR1444M/en
Priority to SE470362A priority patent/SE301967B/xx
Priority to CH510562A priority patent/CH411853A/en
Priority to ES276968A priority patent/ES276968A1/en
Priority to BE617259A priority patent/BE617259A/en
Priority to GB1729162A priority patent/GB976727A/en
Priority to US386370A priority patent/US3198707A/en
Application granted granted Critical
Publication of FR1368727A publication Critical patent/FR1368727A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
FR860746A 1961-05-04 1961-05-04 Estradiol derivatives and method of preparation Expired FR1368727A (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR860746A FR1368727A (en) 1961-05-04 1961-05-04 Estradiol derivatives and method of preparation
FR869787A FR1444M (en) 1961-05-04 1961-08-02 New drug especially for the treatment of ovarian irregularities and insufficiencies.
SE470362A SE301967B (en) 1961-05-04 1962-04-26
CH510562A CH411853A (en) 1961-05-04 1962-04-27 Process for the preparation of estradiol derivatives
ES276968A ES276968A1 (en) 1961-05-04 1962-05-03 Procedure for the preparation of (9-beta) estradiol (Machine-translation by Google Translate, not legally binding)
BE617259A BE617259A (en) 1961-05-04 1962-05-04 Estradiol derivatives and method of preparation
GB1729162A GB976727A (en) 1961-05-04 1962-05-04 Novel estradiol derivatives, processes for their preparation and pharmaceutical compositions incorporating the same
US386370A US3198707A (en) 1961-05-04 1964-07-30 9beta-isomers of estradiol, processes of making the same and their utilization

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR860746A FR1368727A (en) 1961-05-04 1961-05-04 Estradiol derivatives and method of preparation

Publications (1)

Publication Number Publication Date
FR1368727A true FR1368727A (en) 1964-08-07

Family

ID=8754452

Family Applications (2)

Application Number Title Priority Date Filing Date
FR860746A Expired FR1368727A (en) 1961-05-04 1961-05-04 Estradiol derivatives and method of preparation
FR869787A Active FR1444M (en) 1961-05-04 1961-08-02 New drug especially for the treatment of ovarian irregularities and insufficiencies.

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR869787A Active FR1444M (en) 1961-05-04 1961-08-02 New drug especially for the treatment of ovarian irregularities and insufficiencies.

Country Status (2)

Country Link
US (1) US3198707A (en)
FR (2) FR1368727A (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2856520C (en) 2011-11-23 2021-04-06 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
MX2016014281A (en) 2014-05-22 2017-02-22 Therapeuticsmd Inc Natural combination hormone replacement formulations and therapies.
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
MX2018011705A (en) 2016-04-01 2019-06-10 Therapeuticsmd Inc Steroid hormone pharmaceutical composition.
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Also Published As

Publication number Publication date
US3198707A (en) 1965-08-03
FR1444M (en) 1962-08-13

Similar Documents

Publication Publication Date Title
FR1368727A (en) Estradiol derivatives and method of preparation
FR1456779A (en) 7-substituted estratriene derivatives and method of preparation
FR1359662A (en) Colchicium derivatives and method of preparation
FR1301267A (en) New derivatives of oxazolidinone-2 and their preparation methods
FR1453216A (en) New estradiol derivatives and method of preparation
BE617259A (en) Estradiol derivatives and method of preparation
BE616293A (en) 19-nor testosterone derivatives and method of preparation
FR1500757A (en) New indene derivatives and method of preparation of these derivatives
BE618187A (en) New derivatives of 6-methyl- and 1,6-dimethyl-ergoline I and method of preparation
FR1368721A (en) 19-nor testosterone derivatives and method of preparation
FR1369964A (en) Alkyl estradiene derivatives and method of preparation
FR1373654A (en) Hydroxymethyl pregnane derivatives and method of preparation
FR1362095A (en) Process for the preparation of halophospholines and their derivatives
FR1368728A (en) Progesterone derivatives and method of preparation
FR1426075A (en) Substituted derivatives of estradiol and method of preparation
BE615705A (en) Bis-hydroxymethyl pregnane derivatives and method of preparation
BE615643A (en) Bis-hydroxymethyl pregnane derivatives and method of preparation
BE615766A (en) Bis-hydroxymethyl pregnane derivatives and method of preparation
FR1369316A (en) Cortisone derivatives and method of preparation
FR1497453A (en) Ajmaline derivatives and method of preparation
FR1370567A (en) New alkyl derivatives of estradiene and method of preparation
FR83552E (en) Novel ethynyl analogue of estradiol, its functional derivatives and method of preparation
FR1369970A (en) Paromomycin derivatives and method of preparation
FR1315273A (en) Alkoxypropyl-biguanides and method of preparation
FR1368723A (en) 19-nor testosterone derivatives and method of preparation